Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference

GAITHERSBURG, Md., 2016-12-06 22:05 CET (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will participate in the 4th Annual Guggenheim Boston Healthcare Conference.

Conference details are as follows:

Date: Tuesday, December 13, 2016
Location: Intercontinental Boston Hotel, Boston, MA

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website, novavax.com.

Contact:
         
Novavax, Inc.
         
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
         
Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations
         
[e-mail]
240-268-2000
         
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
         
[e-mail]
[e-mail]
212-845-4271

---

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novavax, Inc. via Globenewswire